Initial Treatment Approach for Prostatitis
For acute bacterial prostatitis, the first-line treatment is fluoroquinolones (ciprofloxacin 500 mg twice daily or levofloxacin 500 mg once daily) for 2-4 weeks, while chronic bacterial prostatitis requires 4-6 weeks of antibiotic therapy. 1
Diagnosis and Classification
Before initiating treatment, it's essential to determine the type of prostatitis:
Acute bacterial prostatitis
Chronic bacterial prostatitis
Chronic prostatitis/chronic pelvic pain syndrome
- Most common form, diagnosis of exclusion 4
Asymptomatic prostatitis
- Incidental finding, no treatment required 4
Initial Diagnostic Workup
- Midstream urine dipstick (nitrite and leukocytes)
- Midstream urine culture to guide antibiotic selection
- Blood culture and complete blood count in severe cases
- Transrectal ultrasound if prostatic abscess is suspected 1
Treatment Algorithm
Acute Bacterial Prostatitis
First-line antibiotics:
Alternative options:
For severe cases requiring hospitalization:
Chronic Bacterial Prostatitis
First-line treatment:
For atypical pathogens:
- Chlamydia: azithromycin 1.0-1.5 g single dose or doxycycline 100 mg twice daily for 7 days
- Mycoplasma: azithromycin 500 mg on day 1, then 250 mg for 4 days 1
Important Clinical Considerations
- Avoid prostatic massage during acute bacterial prostatitis 1
- Reassess after 2 weeks to evaluate symptom improvement 1
- Obtain urine culture at end of treatment to confirm eradication 1
- Monitor for fluoroquinolone side effects affecting tendons, muscles, joints, nerves, and central nervous system 1
- Consider prostatic abscess in patients who fail to respond to appropriate antibiotic therapy 1
Common Pitfalls to Avoid
Inadequate treatment duration
Poor antibiotic selection
Overlooking atypical pathogens
- Consider Chlamydia and Mycoplasma in resistant cases 1
Initiating antibiotics without proper diagnosis
- Unless fever is present, complete diagnostic workup before starting antibiotics 3
Failure to monitor for complications
- Watch for prostatic abscess development in non-responsive cases 1
The European Association of Urology guidelines strongly support fluoroquinolones as first-line therapy due to their superior prostatic tissue penetration and documented efficacy 1. While older studies suggested trimethoprim-sulfamethoxazole as an option 5, more recent evidence favors fluoroquinolones for both acute and chronic bacterial prostatitis 1, 2.